Lithium Ion

Lithium Ion

SCHEMBL7651479

Oc1ccc2ccccc2c1-c1cccc2ccccc12.[Al+3].[H-].[H-].[H-].[H-].[Li+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.50
OPRM1 P35372 1/20 0.50
OPRD1 P41143 1/20 0.50
HKDC1 Q2TB90 1/20 0.50
PTPN22 Q9Y2R2 1/20 0.48
CYP1A2 P05177 2/20 0.47
POLB P06746 1/20 0.46
USP2 O75604 1/20 0.44
PAK1 Q13153 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MCL1 Q07820 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
HSP90AA1 P07900 5/20 0.43
HSP90AB1 P08238 5/20 0.43
MAPT P10636 2/20 0.42
DNMT1 P26358 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL214870 0.94 NSD2 (0.54) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL29360295 0.94 NSD2 (0.54) NSD2OPRM1OPRD1HKDC1PTPN22
Hydrochloric Acid SCHEMBL31134043 0.92 PTPN22 (0.57) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL29492615 0.92 NSD2 (0.53) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL1840829 0.92 NSD2 (0.53) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL9060865 0.92 NSD2 (0.53) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL31410627 0.92 NSD2 (0.53) NSD2OPRM1OPRD1HKDC1PTPN22
Hydrochloric Acid SCHEMBL29492626 0.91 NSD2 (0.51) NSD2OPRM1OPRD1HKDC1PTPN22
SCHEMBL5181906 0.91 NSD2 (0.51) NSD2OPRM1OPRD1HKDC1PTPN22
Boric Acid SCHEMBL30888865 0.89 NSD2 (0.50) NSD2OPRM1OPRD1HKDC1PTPN22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0835257-B1 INTERMEDIATES AND PROCESS FOR THE MANUFACTURE OF CAMPTOTHECIN DERIVATIVES (CPT-11) AND RELATED COMPOUNDS UPJOHN CO (US) 2002-09-25 EP disclosed
US-6444820-B1 ANTICARCINOGENIC AGENTS HENEGAR KEVIN E (US) 2002-09-03 US disclosed
US-6235907-B1 Intermediates useful in making mappicine and related compounds PHARMACIA & UPJOHN COMPANY 2001-05-22 US disclosed
EP-0835257-A1 NOVEL INTERMEDIATES AND PROCESS FOR THE MANUFACTURE OF CAMPTOTHECIN DERIVATIVES (CPT-11) AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 1998-04-15 EP disclosed
WO-1996031513-A1 NOVEL INTERMEDIATES AND PROCESS FOR THE MANUFACTURE OF CAMPTOTHECIN DERIVATIVES (CPT-11) AND RELATED COMPOUNDS PHARMACIA & UPJOHN COMPANY (US) 1996-10-10 WO disclosed